Ex vivo anti-tumor activity of rosiglitazone on multiple myeloma cells.

被引：0
|
作者：
Huang, Haiwen
Wu, De Pei
Leung, Anskar Y. H.
Liang, Raymond
Lie, Albert K. W.
机构：
[1] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5052
引用
收藏
页码：352B / 352B
页数：1
相关论文
共 50 条
  • [21] Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma
    Kim, Hwan Mook
    Lim, Jaeseung
    Yoon, Yeo Dae
    Ahn, Ji Mi
    Kang, Jong Soon
    Lee, Kiho
    Park, Song-Kyu
    Jeong, Yu Jin
    Kim, Jin Mi
    Han, Gyoonhee
    Yang, Kyu-Hwan
    Kim, Yeon Jin
    Kim, Youngsoo
    Han, Sang-Bae
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (13) : 1793 - 1801
  • [22] Anti-tumor activity of a novel immunosuppressant FTY720 in multiple myeloma.
    Yasui, H
    Hideshima, T
    Roccaro, AM
    Shiraishi, N
    Hamasaki, M
    Ishitsuka, K
    Kumar, S
    Raje, N
    Li, GL
    Tai, YT
    Podar, K
    Chauhan, D
    Anderson, KC
    BLOOD, 2004, 104 (11) : 941A - 942A
  • [23] Anti-tumor activity of lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors in multiple myeloma (MM).
    Hideshima, T
    Chauhan, D
    Hayashi, T
    Podar, K
    Akiyama, M
    Mitsiades, C
    Mitsiades, N
    Gong, BQ
    Bonham, L
    de Vries, P
    Munshi, NC
    Richardson, PG
    Singer, JW
    Anderson, KC
    BLOOD, 2003, 102 (11) : 451A - 452A
  • [24] BI 836909, a Novel Bispecific T Cell Engager for the Treatment of Multiple Myeloma Induces Highly Specific and Efficacious Lysis of Multiple Myeloma Cells in Vitro and Shows Anti-Tumor Activity in Vivo
    Hipp, Susanne
    Deegen, Petra
    Wahl, Joachim
    Blanset, Diann
    Thomas, Oliver
    Rattel, Benno
    Adam, Paul
    Friedrich, Matthias
    BLOOD, 2015, 126 (23)
  • [25] Ex Vivo Evidence for the Combination of Immune Checkpoint Inhibition with TGF-β Blockade to Enhance Anti-Tumor T Cell Responses in Multiple Myeloma
    Choi, Yoon Seok
    Kwon, Minsuk
    Song, Ik-Chan
    Jo, Deog-Yeon
    Shin, Eui-Cheol
    BLOOD, 2018, 132
  • [26] Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity
    Ozcan, Servet
    Alessio, Nicola
    Acar, Mustafa Burak
    Toprak, Guler
    Gonen, Zeynep Burcin
    Peluso, Gianfranco
    Galderisi, Umberto
    ONCOTARGET, 2015, 6 (37) : 39482 - 39492
  • [27] In vitro expansion of blood γδ T cells in patients with myeloma/lymphoma and anti-tumor cytotoxicity of the expanded γδ T cells.
    Saito, Anri
    Narita, Miwako
    Watanabe, Norihiro
    Tochiki, Nozorni
    Hiroi, Yumi
    Shirasaki, Takayoshi
    Takizawa, Jun
    Furukawa, Tatsuo
    Toba, Ken
    Aoki, Sadao
    Aizawa, Yoshifusa
    Takahashi, Masuhiro
    BLOOD, 2006, 108 (11) : 51B - 51B
  • [28] Combinations of belantamab mafodotin with lenalidomide, pomalidomide, bortezomib and/or dexamethasone synergize in vitro and potentiate in vivo anti-tumor activity in multiple myeloma
    De Oca, Rocio Montes
    Gupta, Ira
    Shelton, Chris
    CANCER RESEARCH, 2020, 80 (16)
  • [29] Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma
    Maillard, S
    Ameller, T
    Gauduchon, J
    Gougelet, A
    Gouilleux, F
    Legrand, P
    Marsaud, V
    Fattal, E
    Sola, B
    Renoir, JM
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 94 (1-3): : 111 - 121
  • [30] Komaroviquinone-Derivatives, Revealed Anti-Tumor Effect on High-Risk Multiple Myeloma Cells In Vitro as Well as In Vivo
    Sato, Mariko
    Fujimori, Kota
    Kitabatake, Shotaro
    Okayama, Mikio
    Ichikawa, Daiju
    Suto, Yutaka
    Iwasaki, Genji
    Kiuchi, Fumiyuki
    Yamaguchi, Takashi
    Ueda, Arimi
    Aida, Shuji
    Nakayama, Hitomi
    Matsushita, Maiko
    Hattori, Yutaka
    BLOOD, 2016, 128 (22)
12345